EE02970B1 - Veeslahustuvate ainete konditsioneerimise protsess - Google Patents

Veeslahustuvate ainete konditsioneerimise protsess

Info

Publication number
EE02970B1
EE02970B1 EE9400417A EE9400417A EE02970B1 EE 02970 B1 EE02970 B1 EE 02970B1 EE 9400417 A EE9400417 A EE 9400417A EE 9400417 A EE9400417 A EE 9400417A EE 02970 B1 EE02970 B1 EE 02970B1
Authority
EE
Estonia
Prior art keywords
soluble substances
conditioning water
vacuum
water
micronised
Prior art date
Application number
EE9400417A
Other languages
English (en)
Estonian (et)
Inventor
Ann-Christin Trofast Eva
Trofast Jan
Bystr�m Katarina
Jakupovic Edib
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20382434&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE02970(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE02970B1 publication Critical patent/EE02970B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
EE9400417A 1991-04-11 1994-11-17 Veeslahustuvate ainete konditsioneerimise protsess EE02970B1 (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9101090A SE9101090D0 (sv) 1991-04-11 1991-04-11 Process for conditioning of water-soluble substances

Publications (1)

Publication Number Publication Date
EE02970B1 true EE02970B1 (et) 1997-04-15

Family

ID=20382434

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400417A EE02970B1 (et) 1991-04-11 1994-11-17 Veeslahustuvate ainete konditsioneerimise protsess

Country Status (28)

Country Link
US (1) US5562923A (fr)
EP (3) EP0508969A1 (fr)
JP (2) JP3400999B2 (fr)
KR (1) KR100216384B1 (fr)
AT (2) ATE137671T1 (fr)
AU (1) AU662519B2 (fr)
BG (1) BG61474B1 (fr)
CA (1) CA2106975C (fr)
CZ (1) CZ286936B6 (fr)
DE (2) DE69232207T2 (fr)
DK (2) DK0680752T3 (fr)
EE (1) EE02970B1 (fr)
ES (2) ES2086733T3 (fr)
FI (1) FI105388B (fr)
GR (1) GR3020602T3 (fr)
HK (1) HK52497A (fr)
HU (1) HU211116B (fr)
IE (1) IE921144A1 (fr)
IS (1) IS3834A (fr)
NO (1) NO311867B1 (fr)
PL (1) PL168232B1 (fr)
PT (1) PT680752E (fr)
RO (1) RO115779B1 (fr)
RU (1) RU2112507C1 (fr)
SE (1) SE9101090D0 (fr)
SG (1) SG43180A1 (fr)
SK (1) SK280310B6 (fr)
WO (1) WO1992018110A1 (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
US5983956A (en) 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
EP0812195B1 (fr) * 1995-02-28 2002-10-30 Aventis Pharmaceuticals Inc. Composition pharmaceutique pour composes de piperidinoalcanol
US5654007A (en) * 1995-06-07 1997-08-05 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
GB9526392D0 (en) 1995-12-22 1996-02-21 Glaxo Group Ltd Medicaments
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700135D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
US6503537B2 (en) 1997-03-20 2003-01-07 Schering Corporation Preparation of powder agglomerates
WO1998041193A1 (fr) * 1997-03-20 1998-09-24 Schering Corporation Preparation d'agglomerats de poudre
US6495167B2 (en) 1997-03-20 2002-12-17 Schering Corporation Preparation of powder agglomerates
PT998272E (pt) * 1997-08-26 2003-09-30 Aventis Pharma Inc Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
JP2001517692A (ja) * 1997-09-29 2001-10-09 インヘール セラピューティック システムズ， インコーポレイテッド ネブライザにおける使用のための安定化調製物
FI105074B (fi) * 1997-12-31 2000-06-15 Leiras Oy Farmaseuttisen formulaation valmistusmenetelmä
US6287693B1 (en) 1998-02-25 2001-09-11 John Claude Savoir Stable shaped particles of crystalline organic compounds
SE9804000D0 (sv) 1998-11-23 1998-11-23 Astra Ab New composition of matter
GB9826284D0 (en) 1998-12-01 1999-01-20 Rhone Poulence Rorer Limited Process
GB9826286D0 (en) 1998-12-01 1999-01-20 Rhone Poulence Rorer Limited Process
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
AR022695A1 (es) * 1999-01-28 2002-09-04 Schering Corp PORTADOR SoLIDO PARTICULADO Y MÉTODO PARA PROVEER CONTROL DE LA PARTICULADA PARA LA DISTRIBUCIoN DE TAMANO DE PARTíCULAS Y DE CONTENIDO AMORFO CONVERTIBLE DURANTE SU PREPARACION
US6623760B1 (en) 1999-01-28 2003-09-23 Schering Corporation Method of preparing particles for agglomeration
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US7309707B2 (en) 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
US7244415B2 (en) 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
US20040028746A1 (en) * 2002-08-06 2004-02-12 Sonke Svenson Crystalline drug particles prepared using a controlled precipitation (recrystallization) process
GB0228826D0 (en) * 2002-12-11 2003-01-15 Okpala Joseph Hair technology in creating particles with improved delivery capabilities
CA2519779A1 (fr) * 2003-03-26 2004-10-14 Teva Pharmaceutical Industries Ltd. Procede de preparation d'un principe actif pharmaceutique a aire de surface specifique elevee
AU2004246870B2 (en) 2003-06-13 2009-07-23 Skendi Finance Ltd Slow release estradiol-progesterone formulation for contraception and hormone replacement therapy
GB0323684D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
EP1675720B1 (fr) * 2003-10-17 2011-11-23 E.I. Du Pont De Nemours And Company Adhesion d'une feuille de metal a des polymeres thermoplastiques
BRPI0506610A (pt) * 2004-02-03 2007-05-02 Chemagis Ltd montelucaste sódico amorfo, processo de preparação de montelucaste sódico amorfo, composição farmacêutica, método de tratamento utilizando a administração de montelucaste sódico amorfo, co-precipitado amorfo de montelucaste sódico e processo de preparação de co-precipitado amorfo de montelucaste sódico
DE102004048389A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
DE102004048390A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pulverinhalativa auf Basis modifizierter Laktosemischungen als Hilfsstoff
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
BRPI0821186A2 (pt) * 2007-12-13 2015-06-16 Novartis Ag Compostos orgânicos
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
WO2011110852A1 (fr) 2010-03-10 2011-09-15 Astrazeneca Ab Formes polymorphes de l'éthylamide de l'acide 6-[2-(4-cyanophényl)-2h-pyrazol-3-yl]-5-méthyl-3-oxo-4-(trifluorométhylphényl)-3,4-dihydropyrazine-2-carboxylique
KR20140036230A (ko) 2011-06-29 2014-03-25 아스트라제네카 아베 글루코코르티코이드 수용체 매개 장애 치료용 인다졸릴 아미드 유도체의 결정질 형태
RU2696582C2 (ru) * 2013-03-15 2019-08-05 Перл Терапьютикс, Инк. Способы и системы кондиционирования дисперсных кристаллических материалов
WO2021219230A1 (fr) 2020-04-30 2021-11-04 Paolo Fiorina Traitement antiviral

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3978192A (en) * 1971-09-23 1976-08-31 Sussman Martin V Method of drawing fibers using a microterraced drawing surface
US4405598A (en) * 1976-01-30 1983-09-20 Fisons, Limited Composition for treating asthma
KR890000664B1 (ko) * 1981-10-19 1989-03-22 바리 안소니 뉴우샘 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법
US4476130A (en) * 1982-09-09 1984-10-09 Riker Laboratories, Inc. 3-(1H-Tetrazol-5-yl)-4H-pyrimido[2,1-b]benzoxazol-4-one compounds exhibiting anti-allergic activity
EP0258258B1 (fr) * 1985-06-21 1989-03-29 Gergely, Gerhard, Dr. Procede et dispositif pour la manipulation de materiau de traitement et le produit de reaction fabrique a l'aide du procede et/ou du dispositif
IT1204826B (it) * 1986-03-04 1989-03-10 Chiesi Farma Spa Composizioni farmaceutiche per inalazione
CA2030581C (fr) * 1989-11-24 2000-06-27 Gunther Atzl Preparations de pancreatine
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles

Also Published As

Publication number Publication date
IE921144A1 (en) 1992-10-21
SG43180A1 (en) 1997-10-17
ES2168322T3 (es) 2002-06-16
CZ211693A3 (en) 1994-04-13
CA2106975C (fr) 2002-03-19
HU9302870D0 (en) 1993-12-28
NO933575L (no) 1993-10-06
FI934429A (fi) 1993-10-08
CZ286936B6 (cs) 2000-08-16
DE69232207D1 (de) 2001-12-20
AU662519B2 (en) 1995-09-07
ES2086733T3 (es) 1996-07-01
EP0580648A1 (fr) 1994-02-02
SK280310B6 (sk) 1999-11-08
EP0680752A3 (fr) 1995-11-22
FI934429A0 (fi) 1993-10-08
JP2003155228A (ja) 2003-05-27
HU211116B (en) 1995-10-30
DK0580648T3 (da) 1996-09-16
PT680752E (pt) 2002-05-31
CA2106975A1 (fr) 1992-10-12
SE9101090D0 (sv) 1991-04-11
EP0680752A2 (fr) 1995-11-08
US5562923A (en) 1996-10-08
EP0508969A1 (fr) 1992-10-14
DE69210601T2 (de) 1996-10-02
RU2112507C1 (ru) 1998-06-10
JP3400999B2 (ja) 2003-04-28
NO933575D0 (no) 1993-10-06
SK108893A3 (en) 1994-03-09
WO1992018110A1 (fr) 1992-10-29
ATE137671T1 (de) 1996-05-15
DE69232207T2 (de) 2002-08-01
PL168232B1 (pl) 1996-01-31
DK0680752T3 (da) 2002-02-25
GR3020602T3 (en) 1996-10-31
BG61474B1 (en) 1997-09-30
HK52497A (en) 1997-05-02
KR100216384B1 (ko) 1999-08-16
DE69210601D1 (de) 1996-06-13
ATE208613T1 (de) 2001-11-15
EP0680752B1 (fr) 2001-11-14
EP0580648B1 (fr) 1996-05-08
RO115779B1 (ro) 2000-06-30
HUT65095A (en) 1994-04-28
NO311867B1 (no) 2002-02-11
AU1534792A (en) 1992-11-17
BG98147A (bg) 1994-12-02
JPH06506454A (ja) 1994-07-21
IS3834A (is) 1992-10-12
FI105388B (fi) 2000-08-15

Similar Documents

Publication Publication Date Title
EE02970B1 (et) Veeslahustuvate ainete konditsioneerimise protsess
RU93058260A (ru) Способ получения водорастворимых микронизированных веществ
JPS5222578A (en) Stabilizing agent for organic materials
CA2211600A1 (fr) Appareillage et methode d'essai pour verifier l'etancheite d'un corps creux
JPS56830A (en) Surface treatment of acrylic resin molded product
DE3164422D1 (en) Immunosuppressive compound, process for isolating it and its therapeutical use
JPS51151693A (en) Coated bead-like activated carbon for blood purification
EP0341696A3 (en) A process for drying water-wet polycarbonate membranes
IT7885588A0 (it) Mezzo propellente adinfiammabilita' ridotta per aerosol, procedimento per la suaproduzione e dispositivo per la realizzazione del procedimento.
JPS51142488A (en) Novel photocromic material
JPS5241192A (en) Process for concentrating or storing ozone by adsorption
JPS51117991A (en) A process for producing oxygen absorbent
JPS53112288A (en) Controlling method for substance permeability of semipermeable membrane
JPS644608A (en) Heat-treated fluorinated polymeric compound
JPS5281078A (en) Permeable membrane module
RU96109577A (ru) Способ проведения оксигенобаротерапии в барокамерах с автономной системой дыхания
JPS526738A (en) Crosslinkable coating materials
GB2019869A (en) Process for the manufacture of 1,2-diaminoanthraquinone
JPS6440922A (en) Dew condensation preventing method for optical unit
JPS5220410A (en) Noise preventiue method of compressor
JPS5288279A (en) Stabilizer for organic materials
HUT52028A (en) Process for producing dichloro-acetyl-chloride with oxidizing trichloro-ethylena
JPS51117317A (en) Transporting method for liquefied gas by means of cargo tank
JPS51117969A (en) Curing apparatus using electron beam irradiation
JPS51139150A (en) Projected entrance type common housing

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231